Jackson Creek Investment Advisors LLC Ironwood Pharmaceuticals Inc Transaction History

Jackson Creek Investment Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 03, 2022	SELL	$10.61 - $12.88 $993,647 - $1.21 Million	-93,652 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$10.86 - $13.95 $71,056 - $91,274	-6,543 Reduced 6.53%	93,652 $1.09 Million
Q3 2021 Nov 02, 2021	BUY	$11.92 - $13.92 $9,571 - $11,177	803 Added 0.81%	100,195 $1.31 Million
Q2 2021 Aug 03, 2021	BUY	$10.16 - $13.11 $1.01 Million - $1.3 Million	99,392 New	99,392 $1.28 Million
Q1 2021 May 27, 2021	SELL	$9.04 - $11.86 $762,759 - $1 Million	-84,376 Closed	0 $0
Q4 2020 Feb 03, 2021	SELL	$9.05 - $12.2 $1,339 - $1,805	-148 Reduced 0.18%	84,376 $961,000
Q3 2020 Nov 09, 2020	BUY	$8.99 - $10.74 $759,870 - $907,787	84,524 New	84,524 $760,000

232

163M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $323M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Jackson Creek Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Jackson Creek Investment Advisors LLC with notifications on news.